Fig. 1 · Structure
Documents & Downloads
Nesfrotamig
Monoclonal Antibody
Nesfrotamig is a humanized dimeric monoclonal antibody that specifically targets the human epidermal growth factor receptor 2 (ERBB2) and tumor necrosis factor receptor superfamily member 9 (TNFRSF9). This antibody exhibits significant potential in cancer research, particularly for ERBB2-positive tumors, making it valuable in the study and treatment of malignancies such as breast and gastric cancer. Its dual-targeting capability may facilitate a deeper understanding of tumor biology and contribute to the development of targeted therapies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2966936-23-0 |
| Applications | Monoclonal Antibody |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.